Dow Corning Presents New Products at CPhI 2014
Dow Corning will present new silicones for topical ingredients, topical excipients, transdermal adhesives, and oral APIs at booth 5R31.
Dow Corning, a company focused on silicone-based technology and silicone chemistry and owned jointly by Dow Chemical Company and Corning, will be present at CPhI Worldwide 2014 in Paris. Dow Corning experts will showcase silicones for pharmaceutical and consumer healthcare applications, silicone ingredients, and BIO-PSA adhesives for attendees at booth 5R31.
“This year is particularly exciting, as it will see the launch of Dow Corning Topical Ingredients—our latest innovation for consumer healthcare topical formulations with new silicone-based ingredients,” stated Myriam Delvaux, Global Marketing Leader Drug Delivery Systems, in a press release.
Patricia Rafidison, Regulatory Affairs Manager, will speak about Dow Corning’s regulatory experience and cGMP production practices at CPhI Speakers Corner in Hall 5A, Stand F 81 on Oct. 7, 2014.
Source: Dow Corning
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
